Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard
The Australian Commission on Safety and Quality in Healthcare is making a clinical care standard to guide medical professionals who are treating people with a cognitive disability or impairment. This includes people who have an intellectual disability.
The Commission wants to reduce the inappropriate use of psychotropic medicines, especially when they are used as a restrictive practice to manage a person’s behaviour.
You can read more about the clinical care standard here: https://www.safetyandquality.gov.au/standards/clinical-care-standards/psychotropic-medicines-cognitive-impairment-and-disability-clinical-care-standard
The new clinical care standard will be launched in 2024.
Inclusion Australia made a submission to the Commission to highlight some of the ways the clinical care standard could be improved to make sure it upholds the human rights of people with an intellectual disability.
You can read our submission here: Psychotropic Medicines in Cognitive Impairment or Disability Clinical Care Standard